Cantor Fitzgerald reiterates Neutral rating on Quantum Computing stock

Cantor Fitzgerald reiterated a Neutral rating on Quantum Computing (QUBT) with a $10 price target, below the current $12.80 share price and InvestingPro’s $10.68 fair value, implying overvaluation. The company reported Q1 2026 EPS of -$0.02 versus -$0.04 expected and revenue of $3.7 million versus $2.8 million expected, while integration progress from the Luminar Semiconductor acquisition and the March NuCrypt acquisition supported Lake Street’s $16 price target. The stock’s cash-rich balance sheet, including about $1.4 billion in cash, remains a key fundamental offset.

Analysis

The key read-through is not about QUBT’s near-term earnings beat; it’s that the stock is increasingly being priced like a strategic platform rather than a pre-scale operating business. That creates a gap between narrative optionality and fundamental proof: if integration keeps lifting revenue while cash remains large, the market will tolerate a much higher multiple, but any slowdown in acquisition-led growth will force a sharp re-rating because the implied terminal value already assumes meaningful share capture far out in the future.

Second-order effects matter more than the headline. A stronger QUBT tape can pull incremental capital into the entire quantum complex, but liquidity will likely concentrate in the most levered beta names first, where valuation is more dependent on future funding access than current demand. That means relative winners can be the names with cleaner balance sheets and fewer near-term dilution concerns; the weaker names risk underperforming even if the sector stays bid, as investors rotate toward perceived execution quality.

The contrarian concern is that the market may be conflating revenue quality with revenue quantity. Acquisition-driven sales can support sentiment for several quarters, but they do not solve the core question of monetization durability or the timing of commercial adoption. If the next couple of prints show slower incremental contribution from acquired assets, the stock could de-rate quickly because the current setup leaves little margin for disappointment, especially with the shares still trading above a conservative fair-value anchor.

From a catalyst standpoint, the next 1-2 earnings cycles matter more than any long-dated market-share model. The stock can continue to squeeze on sector momentum and M&A integration headlines, but the risk/reward becomes asymmetric if the company needs to fund more deals or if broader risk appetite cools. In that scenario, the market will likely revisit enterprise-value-to-sales discipline and the multiple compresses faster than the cash balance can protect the equity.

Key Decisions for Investors

• Short QUBT into post-rally strength on a 1-3 week horizon; thesis is that the current price already discounts integration success and long-dated adoption, with downside to the low-teens or below if momentum fades. Use a tight stop above recent highs because the name can remain squeezable on sector beta.
• Pair long IONQ / short QUBT for a 1-2 month relative-value trade if you want quantum exposure without paying the same acquisition-premium narrative multiple; prefer the name with more diversified market perception and less dependence on acquisition optics.
• Avoid chasing QBTS and RGTIW on sector sympathy unless they can show independent operating acceleration; the risk is that they underperform on any broad market rotation because they have less balance-sheet insulation and more financing sensitivity.
• If staying long QUBT, hedge with short-dated calls or a call spread sale against the position over the next earnings window; the upside is another headline-driven re-rate, but the more likely outcome is range compression after the market digests execution reality.